NHGRI contributes to study that implicates 63 new gene variants in prostate cancer risk

Elaine A. Ostrander, Ph.D., a researcher with the National Human Genome Research Institute, contributed to a new study that has implicated 63 additional genetic variants in prostate cancer risk. Dr. Ostrander and her colleagues based their findings, published inNature Genetics, on DNA samples from more than 140,000 men.
Source: NHGRI Homepage Highlights - Category: Genetics & Stem Cells Source Type: news